Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club (Q37250572)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2009

Language	Label	Description	Also known as
English	Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club	scientific article published on January 2009

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

5 references

13 March 2019

24 March 2019

19 June 2019

12 November 2019

19 November 2020

Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club (English)

1 reference

Europe PubMed Central

19 August 2017

0 references

postmenopausal osteoporosis

5 references

13 March 2019

24 March 2019

19 June 2019

12 November 2019

19 November 2020

organic compound, having C-P covalent bound

1 reference

12 November 2019

1 reference

19 November 2020

author name string

P Bergmann

1

1 reference

Europe PubMed Central

19 August 2017

J-J Body

2

1 reference

Europe PubMed Central

19 August 2017

S Boonen

3

1 reference

Europe PubMed Central

19 August 2017

Y Boutsen

4

1 reference

Europe PubMed Central

19 August 2017

J-P Devogelaer

5

1 reference

Europe PubMed Central

19 August 2017

S Goemaere

6

1 reference

Europe PubMed Central

19 August 2017

J-M Kaufman

7

1 reference

Europe PubMed Central

19 August 2017

J-Y Reginster

8

1 reference

Europe PubMed Central

19 August 2017

V Gangji

9

1 reference

Europe PubMed Central

19 August 2017

Members of Advisory Board on Bone Markers

10

1 reference

Europe PubMed Central

19 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2009

6 references

Europe PubMed Central

19 August 2017

13 March 2019

24 March 2019

19 June 2019

12 November 2019

19 November 2020

International Journal of Clinical Practice

6 references

Europe PubMed Central

19 August 2017

13 March 2019

24 March 2019

19 June 2019

12 November 2019

19 November 2020

63

1 reference

Europe PubMed Central

19 August 2017

1

1 reference

Europe PubMed Central

19 August 2017

19-26

1 reference

Europe PubMed Central

19 August 2017

copyright license

Creative Commons Attribution 2.5 Generic

5 references

Europe PubMed Central

13 March 2019

Europe PubMed Central

24 March 2019

Europe PubMed Central

19 June 2019

Europe PubMed Central

12 November 2019

Europe PubMed Central

19 November 2020

on focus list of Wikimedia project

0 references

Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

Biochemical markers of bone turnover: part I: biochemistry and variability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

Identification of osteopenic women at high risk of fracture: the OFELY study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

Biochemical markers of bone metabolism in the assessment of osteoporosis: useful or not?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

Preanalytical variability of biochemical markers of bone turnover.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

Relationship of bone turnover to bone density and fractures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

Immunoassay for intact amino-terminal propeptide of human type I procollagen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

6 September 2017

Endocrinological status of postmenopausal osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

14 September 2017

How do you know who needs prevention or treatment?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

28 September 2017

Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

28 September 2017

Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

26 June 2018

Prediction of bone loss using biochemical markers of bone turnover.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

3 September 2018

Clinical utility of a pharmacostatistical model for ibandronate in postmenopausal osteoporosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

3 September 2018

Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

3 September 2018

Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

3 September 2018

The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

3 September 2018

Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

3 September 2018

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

3 September 2018

Interlaboratory variation of biochemical markers of bone turnover.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

3 September 2018

Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

3 September 2018

Biochemical markers of bone turnover reflect femoral bone loss in elderly women.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

3 September 2018

Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705815

3 September 2018

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age and sex distribution of alkaline phosphatase isoenzymes by agarose electrophoresis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid bone loss is associated with increased levels of biochemical markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Six osteocalcin assays compared

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of renal function on plasma levels of bone Gla-protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apparent instability of osteocalcin in serum as measured with different commercially available immunoassays

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring of Alendronate Treatment and Prediction of Effect on Bone Mass by Biochemical Markers in the Early Postmenopausal Intervention Cohort Study1

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteocalcin in human serum: a circadian rhythm

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thermal instability of the trimeric structure of the N-terminal propeptide of human procollagen type I in relation to assay technology

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Monitoring Bone Turnover Markers on Persistence with Risedronate Treatment of Postmenopausal Osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Critical differences in the serial measurement of three biochemical markers of bone turnover in the sera of pre- and postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analytical and clinical performance characteristics of Tandem-MP Ostase, a new immunoassay for serum bone alkaline phosphatase

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen

1 reference

https://pubmed.ncbi.nlm.nih.gov/19125989

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1742-1241.2008.01911.X

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37250572&oldid=1697465171"